Overview
Vivici is a Dutch ingredients startup building animal-free dairy proteins, positioning itself as a supplier for food companies seeking dairy functionality without conventional animal inputs. Its focus is on scaling protein ingredients rather than consumer-branded dairy products. The company secured €12.5 million, or about $14 million, in EIC backing in an undisclosed round announced June 18, 2026. The funding provides European support for scaling its animal-free dairy protein platform and advancing commercialization.
Funding History
Dutch ingredients startup Vivici secures €12.5 million EIC backing to scale animal-free dairy proteins
Frequently Asked Questions
- How much funding does AI Funding track for Vivici?
- AI Funding tracks $14M for Vivici across 1 funding round in this database.
- Who are Vivici's investors?
- Vivici's investors include European Innovation Council.
- What does Vivici do?
- Vivici is a Dutch ingredients startup building animal-free dairy proteins, positioning itself as a supplier for food companies seeking dairy functionality without conventional animal inputs. Its focus is on scaling protein ingredients rather than consumer-branded dairy products. The company secured €12.5 million, or about $14 million, in EIC backing in an undisclosed round announced June 18, 2026. The funding provides European support for scaling its animal-free dairy protein platform and advancing commercialization.
- Where is Vivici headquartered?
- Vivici is headquartered in Delft, Netherlands.
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.